Qualitative study on decision-making by prostate cancer physicians during active surveillance (original) (raw)
Decision Making in Prostate-Specific Antigen Screening
Nancy Breen
American Journal of Preventive Medicine, 2006
View PDFchevron_right
Surgical Management After Active Surveillance for Low-Risk Prostate Cancer: Pathological Outcomes Compared with Men Undergoing Immediate Treatment
Benjamin Davies
BJU International, 2011
View PDFchevron_right
Adherence to an Annual PSA Screening Program over 3 Years for Brothers and Sons of Men with Prostate Cancer
Antoine Valéri, Luc Cormier
European Urology, 2004
View PDFchevron_right
An Analysis of Patients with Clinically Localized High-Risk Prostate Carcinoma
Mack Roach
The Prostate Journal, 2000
View PDFchevron_right
Patients’ interest in discussing cancer risk and risk management with primary care physicians
Lori Bastian
Patient Education and Counseling, 2005
View PDFchevron_right
Prostate cancer survivorship
Raj Persad
Trends in Urology & Men's Health, 2014
View PDFchevron_right
Assessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
Scott Lucia
JNCI: Journal of the National Cancer Institute, 2006
View PDFchevron_right
Screening for Prostate Cancer: Opportunities and Challenges
Javier Hernandez
Surgical Oncology Clinics of North America, 2005
View PDFchevron_right
Helping men make an informed decision about prostate cancer screening: A pilot study of telephone counseling
Kat Leung
Patient Education and Counseling, 2011
View PDFchevron_right
Do men with prostate cancer and their partners receive the information they need for optimal illness self-management in the immediate post-diagnostic phase?
Sylvie Lambert
Asia-Pacific Journal of Oncology Nursing, 2015
View PDFchevron_right
Active surveillance vs. radical prostatectomy in favourable-risk localised prostate cancer
Henrik Jakobsen
European Urology Supplements, 2019
View PDFchevron_right
An exploration of men’s experiences of undergoing active surveillance for favourable-risk prostate cancer: A mixed methods study protocol
Eimear Ruane-McAteer
BMC Cancer, 2016
View PDFchevron_right
Considerations of healthcare professionals in medical decision-making about treatment for clinical end-stage cancer patients
Ccd Van Der Rijt
Journal of Pain and Symptom Management, 2004
View PDFchevron_right
Impact of Prostate Cancer Diagnosis on Noncancer Hospitalizations Among Elderly Medicare Beneficiaries With Incident Prostate Cancer
Mohamad Salkini
Journal of the National Comprehensive Cancer Network, 2016
View PDFchevron_right
Screening and treatment of localized prostate cancer decreases mortality: First analysis of the first prospective and randomized study on prostate cancer screening
Bernard Candas
The Aging Male, 1999
View PDFchevron_right
Clinical Stage Evaluation at Diagnosis of Prostate Cancer at Urology-Andrology Clinic Cnhu-Hkm Cotonou
Prince Pascal
Open Journal of Urology, 2015
View PDFchevron_right
The Supportive Care Needs of Men With Advanced Prostate Cancer
Jennifer Blythe
Oncology Nursing Forum, 2011
View PDFchevron_right
Factors Influencing Prostate Cancer Healthcare Practices in Barbados, West Indies
Patricia Ng
Journal of Immigrant and Minority Health, 2012
View PDFchevron_right
Prostate Cancer Risk with Positive Family History, Normal Prostate Examination Findings, and PSA Less Than 4.0 ng/mL
Javier Hernandez
Urology, 2007
View PDFchevron_right
Comparing Prostate Specific Antigen Triggers for Intervention in Men With Stable Prostate Cancer on Active Surveillance
Alexandre Mamedov
Journal of Urology, 2010
View PDFchevron_right
Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011
Jeremy Millar
The Medical Journal of Australia, 2013
View PDFchevron_right
Vancouver General Hospital, The Prostate Cancer Center
Mauricio Neira
2007
View PDFchevron_right
Editorial: Challenges in the prevention of prostate cancer
Andrea Venerando
Frontiers in Oncology, 2023
View PDFchevron_right
Prostate cancer mortality and metastasis under different biopsy frequencies in North American active surveillance cohorts
Jane Lange
Cancer, 2019
View PDFchevron_right
Survival tactics: prostate cancer
Daniel Kelly
1998
View PDFchevron_right